Addex Therapeutics focused on securing new partnerships to fund promising treatments
–News Direct– Addex Therapeutics co-founder and CEO Tim Dyer speaks to Thomas Warner from Proactive about the work that the central nervous system-focused clinical-stage pharmaceutical company has been doing in the promising area of allosteric…